Do-Youn Oh, Tae-Won Kim, Young Suk Park, Sang Joon Shin, Seong Hoon Shin, Eun-Kee Song, Hyo Jin Lee, Kewn-wook Lee and Yung-Jue Bang Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas Cancer 118
Version of Record online: 26 JUN 2012 | DOI: 10.1002/cncr.27675
Everolimus is a promising and well-tolerated agent for treating nonfunctioning neuroendocrine tumors (NETs) regardless of the origin of the primary tumor and demonstrates modest efficacy in the treatment of patients with pheochromocytomas/paragangliomas. The result of the current study support the further study of everolimus in patients with pheochromocytomas/paragangliomas and the incorporation of positron emission tomography in NET studies.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field